Perfil
Mr. John M.
Dunn is a General Counsel at CalciMedica, Inc. He is on the Board of Directors at Agility Clinical, Inc., CONNECT and The University of Wyoming Foundation.
Mr. Dunn was previously employed as an Independent Director by Acer Therapeutics, Inc., a Secretary & General Counsel by Vital Therapies, Inc., an Executive Vice President by Biogen Idec, Inc., an Executive Vice President by Biogen Idec New Ventures, Inc., a Secretary, Senior VP-Legal & Compliance by IDEC Pharmaceuticals Corp., and a Partner by Pillsbury Winthrop LLP.
He also served on the board at Sharp HealthCare, Opexa Therapeutics, Inc., Acer Therapeutics, Inc. /Old/ and Biocom, Inc. He received his undergraduate degree from the University of Wyoming and a graduate degree from the University of Wyoming.
Cargos activos de John Dunn
| Empresas | Cargo | Inicio |
|---|---|---|
| CALCIMEDICA, INC. | Consejero General | 20/03/2023 |
Agility Clinical, Inc.
Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty consulting and clinical research organization | Director/Miembro de la Junta | - |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Director/Miembro de la Junta | - |
The University of Wyoming Foundation
The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de John Dunn.
| Empresas | Cargo | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Director/Miembro de la Junta | 17/11/2023 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Consejero General | 12/04/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Corporate Officer/Principal | 31/12/2008 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Oficial de Cumplimiento | 01/11/2003 |
Formación de John Dunn.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 15 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Agility Clinical, Inc.
Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty consulting and clinical research organization | Commercial Services |
Acer Therapeutics, Inc. /Old/
Acer Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of orphan diseases. | Health Technology |
Pillsbury Winthrop LLP
Pillsbury Winthrop LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Sharp HealthCare
Sharp HealthCare Hospital/Nursing ManagementHealth Services Operates acute care and specialty hospitals | Health Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
The University of Wyoming Foundation
The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation | Miscellaneous |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
CalciMedica, Inc.
CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
- Bolsa de valores
- Insiders
- John Dunn
















